Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer. - Wikidata - wikimedia - TriplyDB

Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer.

Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer.

http://www.wikidata.org/entity/Q37606324

about

Copy number variation and high expression of DNA topoisomerase II alpha predict worse prognosis of cancer: a meta-analysis.

P2860

Q55396428-D068CE0E-9F76-4FDE-ADA7-73451226EFA4

P2860

Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer.

http://www.wikidata.org/entity/Q37606324

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Amplification of HER2 and TOP2 ...... es of Taiwanese breast cancer.

@en

Amplification of HER2 and TOP2 ...... es of Taiwanese breast cancer.

@nl

type

label

Amplification of HER2 and TOP2 ...... es of Taiwanese breast cancer.

@en

Amplification of HER2 and TOP2 ...... es of Taiwanese breast cancer.

@nl

prefLabel

Amplification of HER2 and TOP2 ...... es of Taiwanese breast cancer.

@en

Amplification of HER2 and TOP2 ...... es of Taiwanese breast cancer.

@nl

P1433

Q37606324-4408530F-4FDF-41A2-A001-1AA07DB6DD73

P1476

Q37606324-26195896-72E0-4A6A-9105-544E7AAE68E8

P2093

Q37606324-0E221BBA-36AC-4401-803F-186BB39D3A8D

Q37606324-3B1B6BB8-6BD0-4097-BD40-8E612F7CA6F4

Q37606324-4C8E3D84-9413-48C8-8D84-888AAD08A7F3

Q37606324-61FB8BE7-3C84-4F54-92F9-EDDDB5F4B00F

Q37606324-743824F2-9A88-40AE-BB14-0466CAAD12C1

Q37606324-920D9782-3EC2-446B-B9BD-8F1600FC9BE8

Q37606324-97B7A5CC-90D0-461E-A369-47C1BCBC4C19

Q37606324-A269A5AF-4088-4289-A079-EC8F4721C13A

Q37606324-A3E506E3-245C-423F-BC4C-5433FBAFFD0F

Q37606324-B541BF10-B4E3-492E-8E16-F2FF3F6656FC

P2860

Q37606324-0BF2E8E1-C54A-4DD1-A57F-DF02465870E0

Q37606324-178035C6-AAEE-4C0F-9787-3901FEFC74BA

Q37606324-20CB491A-0289-442C-908E-370297710C69

Q37606324-22842AC0-71DE-4538-9580-C53C8AC59992

Q37606324-2A17DFB8-409E-4B0D-BDA6-903427D163D5

Q37606324-2C12EAAF-7E17-4F0C-8859-49A93EE2379D

Q37606324-2E171686-35CF-4650-A54A-8D4334E02CF8

Q37606324-32848B95-164E-4306-A660-2105066D69B2

Q37606324-362911B4-61DC-49D0-AC1E-68612D26E3C8

Q37606324-4629351A-CADA-4CCE-80E3-ACCBC057AE8B

P304

Q37606324-E75A1795-65CA-46B4-B49F-BD843FB0699B

P31

Q37606324-D72ED7F5-AFED-4D8E-B8E5-AE30A5792633

P356

Q37606324-42032614-5484-4FBA-871D-D8045152D314

P407

Q37606324-837842FC-F0AC-4E95-AF06-4830D5938A78

P433

Q37606324-EF11A6FA-D8E3-484F-A5B3-AE1AAED23BF7

P478

Q37606324-B999B1CD-4D97-46C7-812A-6567229B9954

P577

Q37606324-C19A2989-6195-440F-95E5-030F81371900

P698

Q37606324-226F5B54-1817-485F-81E2-1E35732983BD

P932

Q37606324-7D27BFEE-EE6F-40EB-8730-860545694BCF

P356

MD.0000000000005582

P1433

P1476

Amplification of HER2 and TOP2 ...... es of Taiwanese breast cancer.

@en

P2093

Cheng-Cheng Hwang

http://www.w3.org/2001/XMLSchema#string

Chung-Ching Hua

http://www.w3.org/2001/XMLSchema#string

Huang-Yang Chen

http://www.w3.org/2001/XMLSchema#string

Hui-Ping Chien

http://www.w3.org/2001/XMLSchema#string

Jim-Ray Chen

http://www.w3.org/2001/XMLSchema#string

Kun-Yan Yeh

http://www.w3.org/2001/XMLSchema#string

Kuo-Su Chen

http://www.w3.org/2001/XMLSchema#string

Liang-Che Chang

http://www.w3.org/2001/XMLSchema#string

Ren-Jie Lu

http://www.w3.org/2001/XMLSchema#string

Tsan-Yu Hsieh

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive molecular portraits of human breast tumours

HER2/neu in systemic therapy for women with breast cancer: a systematic review.

ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Genomic instability in breast cancer: pathogenesis and clinical implications

HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data.

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines.

Assessment of Topoisomerase II α status in breast cancer by quantitative PCR, gene expression microarrays, immunohistochemistry, and fluorescence in situ hybridization.

Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also.

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.

P304

e5582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000005582

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28079792

http://www.w3.org/2001/XMLSchema#string

P932

5266154

http://www.w3.org/2001/XMLSchema#string